We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDP
3301
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
$82K ﹤0.01%
10,727
+7,968
+289% +$61.7K
XEC
3302
DELISTED
CIMAREX ENERGY CO
XEC
$82K ﹤0.01%
3,373
-7,394
-69% -$195K
CHRS icon
3303
Coherus Oncology
CHRS
$179M
$81K ﹤0.01%
4,417
-9,248
-68% -$172K
MRBK icon
3304
Meridian
MRBK
$241M
$81K ﹤0.01%
10,028
-39,598
-80% -$296K
NSLR
3305
Neostellar Capital Corp
NSLR
$280M
$81K ﹤0.01%
8,941
+8,050
+903% +$84.3K
FARM
3306
DELISTED
Farmer Brothers
FARM
$80K ﹤0.01%
17,968
+15,264
+564% +$90.5K
PROV icon
3307
Provident Financial
PROV
$112M
$80K ﹤0.01%
6,736
+5,518
+453% +$67.5K
NARI
3308
DELISTED
Inari Medical, Inc. Common Stock
NARI
$80K ﹤0.01%
+1,165
New +$74.9K
APTX
3309
DELISTED
Aptinyx Inc. Common Stock
APTX
$80K ﹤0.01%
23,643
+1,665
+8% +$6.38K
PFHD
3310
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$80K ﹤0.01%
5,974
+955
+19% +$12K
CFRX
3311
DELISTED
ContraFect Corporation
CFRX
$80K ﹤0.01%
188
+180
+2,250% +$81.7K
BKLN icon
3312
Invesco Senior Loan ETF
BKLN
$6.76B
$79K ﹤0.01%
+3,638
New +$79.1K
CDNA icon
3313
CareDx
CDNA
$2.35B
$79K ﹤0.01%
2,072
-513
-20% -$17.3K
EUFN icon
3314
iShares MSCI Europe Financials ETF
EUFN
$4.32B
$79K ﹤0.01%
5,755
+887
+18% +$13.1K
GCBC icon
3315
Greene County Bancorp
GCBC
$595M
$79K ﹤0.01%
7,228
+3,836
+113% +$42.5K
GYRE icon
3316
Gyre Therapeutics
GYRE
$695M
$79K ﹤0.01%
2,443
+933
+62% +$36.5K
LARK icon
3317
Landmark Bancorp
LARK
$196M
$79K ﹤0.01%
4,950
-7,843
-61% -$126K
PXLW icon
3318
Pixelworks
PXLW
$44.2M
$79K ﹤0.01%
3,201
+469
+17% +$15.2K
RMNI icon
3319
Rimini Street
RMNI
$471M
$79K ﹤0.01%
24,615
+20,169
+454% +$92.7K
RWX icon
3320
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
$79K ﹤0.01%
2,652
+2,246
+553% +$67.2K
SNN icon
3321
Smith & Nephew
SNN
$12.5B
$79K ﹤0.01%
2,026
+1,262
+165% +$50.8K
GBL
3322
DELISTED
GAMCO Investors, Inc.
GBL
$79K ﹤0.01%
6,802
-602
-8% -$7.56K
KOD icon
3323
Kodiak Sciences
KOD
$2.57B
$78K ﹤0.01%
1,315
-6,123
-82% -$307K
NKTX icon
3324
Nkarta
NKTX
$167M
$78K ﹤0.01%
+2,597
New +$76.5K
PAC icon
3325
Grupo Aeroportuario del Pacifico
PAC
$12.3B
$78K ﹤0.01%
973
+764
+366% +$55.4K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.